FTII
FutureTech II Acquisition
FTII24
$10.96arrow_drop_up0.36%$0.04
FTII
FTII24
$10.96
arrow_drop_up0.36%Performance History
| Key Stats | |
|---|---|
| Open | $10.96 |
| Prev. Close | $10.95 |
| EPS | 0.32 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $63.89M |
| LOW | HIGH | |
|---|---|---|
| Day Range | 10.96 | 10.96 |
| 52 Week Range | 10.76 | 12.20 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | 0.32 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About FutureTech II Acquisition (FTII)
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Mr. Yuquan Wang
- Headquarters
- New Rochelle
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on FutureTech II Acquisition
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is FutureTech II Acquisition (FTII) stock price performance year to date (YTD)?
As of the latest data, FutureTech II Acquisition (FTII) has a year-to-date price change of 1.01%. Over the past month, the stock has experienced a price change of -2.23%. Over the last three months, the change has been 0.46%. Over the past six months, the figure is -1.17%.
help
What is FutureTech II Acquisition's (FTII) price per share?
The current price per share for FutureTech II Acquisition (FTII) is $10.96. The stock has seen a price change of $0.04 recently, indicating a 0.37% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for FutureTech II Acquisition (FTII)?
For FutureTech II Acquisition (FTII), the 52-week high is $12.2, which is 11.31% from the current price. The 52-week low is $10.76, the current price is 1.86% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is FutureTech II Acquisition (FTII) a growth stock?
FutureTech II Acquisition (FTII) has shown an average price growth of -6.8% over the past three years. It has received a score of 54 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying FutureTech II Acquisition as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
Is FutureTech II Acquisition (FTII) a profitable company?
FutureTech II Acquisition (FTII) has a net income of $2.91M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$862.7K. Furthermore, the EBITDA is $0.
help
What is the market capitalization of FutureTech II Acquisition (FTII)?
FutureTech II Acquisition (FTII) has a market capitalization of $63.89M. The average daily trading volume is 10.96, indicating the stock's liquidity and investor engagement.
News
LONGEVITY BIOMEDICAL
FUTURETECH II ACQUISITION CORP.
BUSINESS COMBINATION
BIOPHARMACEUTICAL
HEALTH SPAN
THERAPEUTICS
HEALTH MONITORING
DIGITAL HEALTH
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
PRESS RELEASES
FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination